Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06690775
Title CATALINA-2: a Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors TORL Biotherapeutics, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Medical Center RECRUITING Los Angeles California 90095 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field